These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1129 related articles for article (PubMed ID: 32024712)

  • 1. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.
    Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation.
    Ishizaka A; Koga M; Mizutani T; Parbie PK; Prawisuda D; Yusa N; Sedohara A; Kikuchi T; Ikeuchi K; Adachi E; Koibuchi T; Furukawa Y; Tojo A; Imoto S; Suzuki Y; Tsutsumi T; Kiyono H; Matano T; Yotsuyanagi H
    Microbiol Spectr; 2021 Sep; 9(1):e0070821. PubMed ID: 34378948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients.
    Villanueva-Millán MJ; Pérez-Matute P; Recio-Fernández E; Lezana Rosales JM; Oteo JA
    J Int AIDS Soc; 2017 Mar; 20(1):21526. PubMed ID: 28362071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
    Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
    Front Immunol; 2021; 12():688886. PubMed ID: 34135912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune activation and inflammation in lactating women on combination antiretroviral therapy: role of gut dysfunction and gut microbiota imbalance.
    Munjoma PT; Chandiwana P; Wyss J; Mazhandu AJ; Jordi SBU; Gutsire R; Katsidzira L; Yilmaz B; Misselwitz B; Duri K
    Front Immunol; 2023; 14():1280262. PubMed ID: 38045684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of antiretroviral treatment on immunity and gut microbiome composition in people living with HIV in rural versus urban Zimbabwe.
    Burkhart Colorado AS; Lazzaro A; Neff CP; Nusbacher N; Boyd K; Fiorillo S; Martin C; Siebert JC; Campbell TB; Borok M; Palmer BE; Lozupone C
    Microbiome; 2024 Feb; 12(1):18. PubMed ID: 38310301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota diversity predicts immune status in HIV-1 infection.
    Nowak P; Troseid M; Avershina E; Barqasho B; Neogi U; Holm K; Hov JR; Noyan K; Vesterbacka J; Svärd J; Rudi K; Sönnerborg A
    AIDS; 2015 Nov; 29(18):2409-18. PubMed ID: 26355675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of HIV/HAART and Other Clinical Variables on the Oral Mycobiome Using Multivariate Analyses.
    Fidel PL; Thompson ZA; Lilly EA; Granada C; Treas K; Dubois KR; Cook L; Hashmi SB; Lisko DJ; Mukherjee C; Vazquez JA; Hagensee ME; Griffen AL; Leys EJ; Beall CJ
    mBio; 2021 Mar; 12(2):. PubMed ID: 33758093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration in Oral Microbiome Among Men Who Have Sex With Men With Acute and Chronic HIV Infection on Antiretroviral Therapy.
    Li S; Zhu J; Su B; Wei H; Chen F; Liu H; Wei J; Yang X; Zhang Q; Xia W; Wu H; He Q; Zhang T
    Front Cell Infect Microbiol; 2021; 11():695515. PubMed ID: 34336719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine.
    Ray S; Narayanan A; Giske CG; Neogi U; Sönnerborg A; Nowak P
    ACS Infect Dis; 2021 May; 7(5):1104-1115. PubMed ID: 33346662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Microbiome in HIV-Infected Women: Shifts in the Abundance of Pathogenic and Beneficial Bacteria Are Associated with Aging, HIV Load, CD4 Count, and Antiretroviral Therapy.
    Lewy T; Hong BY; Weiser B; Burger H; Tremain A; Weinstock G; Anastos K; George MD
    AIDS Res Hum Retroviruses; 2019 Mar; 35(3):276-286. PubMed ID: 29808701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of Gut Barrier Function and Microbial Translocation Associate with Lower Gut Microbial Diversity in People with HIV.
    Ellis RJ; Iudicello JE; Heaton RK; Isnard S; Lin J; Routy JP; Gianella S; Hoenigl M; Knight R
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered gut microbiome composition in HIV infection: causes, effects and potential intervention.
    Bandera A; De Benedetto I; Bozzi G; Gori A
    Curr Opin HIV AIDS; 2018 Jan; 13(1):73-80. PubMed ID: 29045252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-Associated Interactions Between Oral Microbiota and Mucosal Immune Cells: Knowledge Gaps and Future Directions.
    Coker MO; Cairo C; Garzino-Demo A
    Front Immunol; 2021; 12():676669. PubMed ID: 34616391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating LPS and (1→3)-β-D-Glucan: A Folie à Deux Contributing to HIV-Associated Immune Activation.
    Ramendra R; Isnard S; Mehraj V; Chen J; Zhang Y; Finkelman M; Routy JP
    Front Immunol; 2019; 10():465. PubMed ID: 30967860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent Effects of HIV and Antiretroviral Therapy on the Oral Microbiome Identified by Multivariate Analyses.
    Beall CJ; Lilly EA; Granada C; Treas K; Dubois KR; Hashmi SB; Vazquez JA; Hagensee ME; Griffen AL; Leys EJ; Fidel PL
    mBio; 2023 Jun; 14(3):e0040923. PubMed ID: 37071004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-Related Variation of Bacterial and Fungal Communities in Different Body Habitats across the Young, Elderly, and Centenarians in Sardinia.
    Wu L; Zeng T; Deligios M; Milanesi L; Langille MGI; Zinellu A; Rubino S; Carru C; Kelvin DJ
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32102941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct gut microbiota profile in antiretroviral therapy-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers.
    Sessa L; Reddel S; Manno E; Quagliariello A; Cotugno N; Del Chierico F; Amodio D; Capponi C; Leone F; Bernardi S; Rossi P; Putignani L; Palma P
    AIDS; 2019 May; 33(6):1001-1011. PubMed ID: 30946154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily variations of gut microbial translocation markers in ART-treated HIV-infected people.
    Ouyang J; Isnard S; Lin J; Fombuena B; Chatterjee D; Wiche Salinas TR; Planas D; Cattin A; Fert A; Moreira Gabriel E; Raymond Marchand L; Zhang Y; Finkelman M; Chen Y; Kaufmann DE; Cermakian N; Ancuta P; Routy JP
    AIDS Res Ther; 2020 May; 17(1):15. PubMed ID: 32398104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune status.
    Presti RM; Handley SA; Droit L; Ghannoum M; Jacobson M; Shiboski CH; Webster-Cyriaque J; Brown T; Yin MT; Overton ET
    AIDS; 2018 Jun; 32(10):1279-1287. PubMed ID: 29851662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.